An Interview with Dr. Eugene Braunwald
Author(s) -
Misia Landau
Publication year - 2011
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2011.165845
Subject(s) - medicine , creativity , myocardial infarction , cardiology , law , political science
In the early 1950s, when Eugene Braunwald was just entering cardiology, there was not a lot a doctor could do for a patient with a heart attack or heart failure. Some heart diseases were beyond diagnosis. Using cardiac catheters and other tools, Braunwald would literally probe the heart for answers to such basic questions as how the heart pumps blood and how it uses oxygen, laying the foundation for modern cardiovascular physiology. In 1959, he and colleagues identified a whole new disease, hypertrophic cardiomyopathy. He followed that up with an even more stunning discovery— that heart attacks could be arrested as they were happening. Braunwald has spent decades researching and testing ways to stop—and prevent— heart disease. He has taught, written over a thousand journal articles, authored and edited classic textbooks, held top administrative posts, and lectured around the world. He is a member of numerous societies, including the National Academy of Sciences. In 1984, he established the Thrombolysis in Myocardial Infarction (TIMI) trials, where he works daily. His office walls are covered with awards and honorary degrees. The most treasured is his honorary doctorate from the University of Vienna. Braunwald, who is the Hersey Distinguished Professor of Medicine at Harvard Medical School and Founding Chairman of the TIMI Study Group, spoke with me in his office.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom